End-of-day quote
Nyse
06:00:00 2024-04-23 pm EDT
|
5-day change
|
1st Jan Change
|
14.38
USD
|
0.00%
|
|
+3.01%
|
-16.54%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,463
|
4,027
|
4,668
|
7,334
|
6,562
|
5,395
|
-
|
-
|
Enterprise Value (EV)
1 |
5,894
|
5,634
|
6,479
|
7,334
|
11,532
|
10,033
|
10,442
|
10,632
|
P/E ratio
|
115
x
|
56.9
x
|
70.3
x
|
128
x
|
-23.3
x
|
-31.2
x
|
-35
x
|
-46.1
x
|
Yield
|
3.6%
|
4.05%
|
3.82%
|
6.43%
|
7.2%
|
8.77%
|
8.77%
|
8.77%
|
Capitalization / Revenue
|
9.49
x
|
8.06
x
|
8.73
x
|
7.86
x
|
4.88
x
|
4.08
x
|
3.95
x
|
3.89
x
|
EV / Revenue
|
12.5
x
|
11.3
x
|
12.1
x
|
7.86
x
|
8.58
x
|
7.59
x
|
7.64
x
|
7.66
x
|
EV / EBITDA
|
23.2
x
|
20.9
x
|
22.5
x
|
13.7
x
|
14.7
x
|
12.8
x
|
12.9
x
|
12.9
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.37
x
|
2.12
x
|
2.18
x
|
0.97
x
|
0.96
x
|
0.88
x
|
0.97
x
|
-
|
Nbr of stocks (in thousands)
|
133,736
|
136,054
|
147,542
|
380,572
|
380,874
|
381,513
|
-
|
-
|
Reference price
2 |
33.37
|
29.60
|
31.64
|
19.27
|
17.23
|
14.14
|
14.14
|
14.14
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/22/22
|
3/1/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
470.3
|
499.6
|
534.8
|
932.6
|
1,344
|
1,322
|
1,367
|
1,387
|
EBITDA
1 |
253.7
|
269.8
|
288.4
|
535.9
|
784.9
|
780.9
|
810
|
821.6
|
EBIT
1 |
75.87
|
79.42
|
85.68
|
82.78
|
54.22
|
63.33
|
91.81
|
104.9
|
Operating Margin
|
16.13%
|
15.89%
|
16.02%
|
8.88%
|
4.03%
|
4.79%
|
6.72%
|
7.56%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
66.66
|
-
|
-282.1
|
-177
|
-142
|
-118
|
Net income
1 |
39.18
|
72.2
|
66.66
|
40.9
|
-278.3
|
-174.9
|
-156.9
|
-118
|
Net margin
|
8.33%
|
14.45%
|
12.46%
|
4.39%
|
-20.71%
|
-13.23%
|
-11.48%
|
-8.51%
|
EPS
2 |
0.2900
|
0.5200
|
0.4500
|
0.1500
|
-0.7400
|
-0.4533
|
-0.4040
|
-0.3066
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.200
|
1.200
|
1.210
|
1.240
|
1.240
|
1.240
|
1.240
|
1.240
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/22/22
|
3/1/23
|
2/16/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
136.6
|
136.4
|
142.9
|
145.3
|
306.4
|
338.1
|
332.9
|
338.1
|
342.3
|
330.4
|
325.5
|
327.8
|
331.7
|
334.9
|
339
|
EBITDA
1 |
72.91
|
74.49
|
74.39
|
77.78
|
177.1
|
206.6
|
196
|
197.3
|
197.2
|
194.5
|
191.8
|
193.6
|
193.9
|
198.1
|
200.5
|
EBIT
1 |
-
|
22.68
|
20.35
|
22.05
|
19.02
|
21.36
|
11.47
|
14.09
|
14.24
|
14.42
|
9.601
|
11.09
|
14.42
|
20.6
|
22.75
|
Operating Margin
|
-
|
16.63%
|
14.24%
|
15.17%
|
6.21%
|
6.32%
|
3.45%
|
4.17%
|
4.16%
|
4.36%
|
2.95%
|
3.38%
|
4.35%
|
6.15%
|
6.71%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-41.68
|
-48.63
|
-45.31
|
-43.17
|
-39.9
|
-40.28
|
Net income
1 |
-2.066
|
21.61
|
42.23
|
6.13
|
28.3
|
-35.76
|
-87.12
|
-82.76
|
-67.84
|
-40.53
|
-47.87
|
-44.8
|
-44.78
|
-41.42
|
-39.88
|
Net margin
|
-1.51%
|
15.84%
|
29.55%
|
4.22%
|
9.24%
|
-10.58%
|
-26.17%
|
-24.47%
|
-19.82%
|
-12.27%
|
-14.71%
|
-13.67%
|
-13.5%
|
-12.37%
|
-11.76%
|
EPS
2 |
-0.0200
|
0.1400
|
0.2800
|
0.0400
|
0.0800
|
-0.2000
|
-0.2300
|
-0.2200
|
-0.1800
|
-0.1100
|
-0.1269
|
-0.1190
|
-0.1191
|
-0.1085
|
-0.1012
|
Dividend per Share
2 |
0.3025
|
0.3025
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
0.3100
|
Announcement Date
|
11/3/21
|
2/22/22
|
5/5/22
|
8/9/22
|
11/9/22
|
3/1/23
|
5/9/23
|
8/8/23
|
11/3/23
|
2/16/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,431
|
1,606
|
1,811
|
-
|
4,969
|
4,639
|
5,047
|
5,237
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
5.642
x
|
5.953
x
|
6.279
x
|
-
|
6.331
x
|
5.94
x
|
6.232
x
|
6.375
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
2.17%
|
3.75%
|
3.23%
|
0.84%
|
-2.17%
|
-2.93%
|
-2.81%
|
-2.86%
|
ROA (Net income/ Total Assets)
|
1.16%
|
1.96%
|
1.65%
|
-
|
-2.1%
|
-1.55%
|
-1.33%
|
-1.09%
|
Assets
1 |
3,377
|
3,688
|
4,036
|
-
|
13,244
|
11,271
|
11,764
|
10,814
|
Book Value Per Share
2 |
14.10
|
14.00
|
14.50
|
19.90
|
17.90
|
16.00
|
14.60
|
-
|
Cash Flow per Share
|
-
|
-
|
1.630
|
1.070
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
231
|
-
|
100
|
100
|
Capex / Sales
|
-
|
-
|
-
|
-
|
17.19%
|
-
|
7.32%
|
7.21%
|
Announcement Date
|
2/12/20
|
2/10/21
|
2/22/22
|
3/1/23
|
2/16/24
|
-
|
-
|
-
|
Last Close Price
14.14
USD Average target price
16.33
USD Spread / Average Target +15.51% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.54% | 5.39B | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | +8.62% | 3.28B | | -2.31% | 3.23B | | -5.42% | 3.06B | | -8.15% | 2.73B | | +12.61% | 2.73B |
Healthcare REITs
|